<?xml version="1.0" encoding="UTF-8"?>
<ref id="B5">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Coorens</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Schneider</surname>
    <given-names>V. A.</given-names>
   </name>
   <name>
    <surname>de Groot</surname>
    <given-names>A. M.</given-names>
   </name>
   <name>
    <surname>van Dijk</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Meijerink</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wells</surname>
    <given-names>J. M.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2017</year>). 
  <article-title>Cathelicidins inhibit 
   <italic>Escherichia coli</italic>–induced tlr2 and tlr4 activation in a viability-dependent manner.
  </article-title>
  <source>
   <italic>J. Immunol.</italic>
  </source>
  <volume>199</volume>
  <fpage>1418</fpage>–
  <lpage>1428</lpage>. 
  <pub-id pub-id-type="doi">10.4049/jimmunol.1602164</pub-id>
  <?supplied-pmid 28710255?>
  <pub-id pub-id-type="pmid">28710255</pub-id>
 </mixed-citation>
</ref>
